Skip to main content

US ClosedU.S. Closed

INO: Inovio Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments.

52W Range

30thpctl

Volume

0.51×avg

Market Cap

89.13MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Inovio Pharmaceuticals, Inc.

INONASDAQ Global Select·USD·Closed

Inovio Pharmaceuticals, Inc.

INONASDAQ·USD·Closed

$1.29

+2.38%

$1.29

+$0.03 (2.38%)

52W Range

30thpctl

Volume

0.51×avg

Mkt Cap

89.13MUSD

P/E

-1.1TTM

Div Yield

–ann